Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-05 Sale |
2022-07-06 4:19 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
25,000 | $30.07 | $751,653 | 874,460 (Indirect Direct) |
View |
| 2022-04-11 Sale |
2022-04-13 5:53 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
5,000 | $30.55 | $152,745 | 899,460 (Indirect Direct) |
View |
| 2022-04-04 Sale |
2022-04-05 6:53 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
17,080 | $50.09 | $855,522 | 247,414 (Direct) |
View |
| 2022-04-04 Sale |
2022-04-05 6:52 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
20,942 | $50.01 | $1,047,317 | 2,592,141 (Indirect Direct) |
View |
| 2022-04-05 Sale |
2022-04-05 6:52 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $50.48 | $504,769 | 355,813 (Direct) |
View |
| 2022-03-21 Sale |
2022-03-21 7:55 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
10,000 | $49.07 | $490,670 | 904,460 (Indirect Direct) |
View |
| 2022-03-15 Sale |
2022-03-16 5:18 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $41.92 | $419,241 | 365,813 (Direct) |
View |
| 2022-03-10 Sale |
2022-03-10 5:41 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
10,000 | $46.94 | $469,374 | 914,460 (Indirect Direct) |
View |
| 2022-03-07 Sale |
2022-03-08 7:43 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $44.94 | $449,387 | 375,813 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 5:11 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
20,942 | $49.98 | $1,046,649 | 2,613,083 (Indirect Direct) |
View |
| 2022-02-22 Sale |
2022-02-23 8:12 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
10,000 | $49.09 | $490,933 | 924,460 (Indirect Direct) |
View |
| 2022-02-23 Sale |
2022-02-23 8:12 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
1,913 | $49.1 | $93,921 | 264,494 (Direct) |
View |
| 2022-02-15 Sale |
2022-02-15 6:35 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $51.93 | $519,295 | 385,813 (Direct) |
View |
| 2022-02-10 Sale |
2022-02-14 9:11 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
14,688 | $52.47 | $770,633 | 987,205 (Indirect Direct) |
View |
| 2022-02-14 Sale |
2022-02-14 9:10 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
601 | $50.23 | $30,188 | 40,212 (Direct) |
View |
| 2022-02-14 Sale |
2022-02-14 9:10 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Pinto Alexis Chief Legal Officer |
691 | $50.23 | $34,708 | 60,729 (Direct) |
View |
| 2022-02-14 Sale |
2022-02-14 9:09 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
7,188 | $50.19 | $360,775 | 415,058 (Direct) |
View |
| 2022-02-14 Sale |
2022-02-14 9:08 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
4,733 | $50.23 | $237,733 | 2,752,344 (Indirect Direct) |
View |
| 2022-02-07 Sale |
2022-02-07 9:53 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $53.45 | $534,474 | 387,203 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 8:03 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
20,942 | $57.77 | $1,209,892 | 2,588,327 (Indirect Direct) |
View |
| 2022-01-18 Sale |
2022-01-20 7:15 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
30,000 | $61.36 | $1,840,745 | 411,097 (Direct) |
View |
| 2022-01-20 Sale |
2022-01-20 7:14 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
10,000 | $59.99 | $599,912 | 926,667 (Indirect Direct) |
View |
| 2022-01-18 Sale |
2022-01-19 7:21 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $62.64 | $626,376 | 397,203 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-11 6:55 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
10,000 | $68.41 | $684,097 | 936,667 (Indirect Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 5:49 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
20,942 | $79.38 | $1,662,308 | 2,609,269 (Indirect Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 5:49 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $83.74 | $83,740 | 43,000 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-05 5:49 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $75.49 | $754,861 | 407,203 (Direct) |
View |
| 2021-12-20 Sale |
2021-12-21 6:17 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
10,000 | $79.24 | $792,431 | 955,417 (Indirect Direct) |
View |
| 2021-12-15 Sale |
2021-12-16 5:18 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $74.03 | $740,337 | 417,203 (Direct) |
View |
| 2021-12-10 Sale |
2021-12-13 6:09 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
10,000 | $71.71 | $717,106 | 965,417 (Indirect Direct) |
View |
| 2021-12-06 Sale |
2021-12-07 8:35 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
10,000 | $71.33 | $713,300 | 427,203 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-02 7:16 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
20,942 | $77.38 | $1,620,527 | 2,645,211 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-08 Option Award |
2022-06-10 4:22 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
24,871 | $0 | 108,330 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:21 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Kariuki Enoch Director |
21,817 | $0 | 21,817 (Direct) |
View |
Ownership |
2022-06-03 10:54 am |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
0 | $0 | 9,199,973 (Indirect) |
View |
| 2022-05-30 Option Award |
2022-05-31 4:06 pm |
N/A 2032-05-29 |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam President |
444,290 | $0 | 800,103 (Direct) |
View |
| 2022-05-16 Option Award |
2022-05-20 4:27 pm |
N/A 2032-05-15 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly President & CEO |
2,136,011 | $0 | 2,136,011 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 9:11 pm |
N/A 2032-02-09 |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
75,226 | $0 | 987,205 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 9:10 pm |
N/A 2032-02-09 |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
34,563 | $0 | 40,212 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 9:10 pm |
N/A 2032-02-09 |
Zentalis Pharmaceuticals Inc. | ZNTL | Pinto Alexis Chief Legal Officer |
54,894 | $0 | 60,729 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 9:09 pm |
N/A 2032-02-09 |
Zentalis Pharmaceuticals Inc. | ZNTL | Epperly Melissa B Chief Financial Officer |
54,894 | $0 | 304,896 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 9:09 pm |
N/A 2032-02-09 |
Zentalis Pharmaceuticals Inc. | ZNTL | Gallagher Cam Director |
35,043 | $0 | 415,058 (Direct) |
View |
| 2022-02-10 Option Award |
2022-02-14 9:08 pm |
N/A 2032-02-09 |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
168,750 | $0 | 2,752,344 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 7:15 pm |
N/A 2030-03-25 |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
30,000 | $0 | 411,097 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 7:15 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Voliotis Dimitris SVP, Clinical Development |
30,000 | $18 | 411,097 (Direct) |
View |
| 2021-12-30 Gift |
2022-01-11 6:55 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Bunker Kevin D. Chief Operating Officer |
8,750 | $0 | 936,667 (Direct) |
View |
| 2021-12-16 Gift |
2022-01-05 5:49 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
15,000 | $0 | 2,609,269 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:49 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $47.8 | 43,000 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 5:49 pm |
N/A 2030-06-30 |
Zentalis Pharmaceuticals Inc. | ZNTL | Blackwell Kimberly Director |
1,000 | $0 | 43,000 (Direct) |
View |
| 2021-06-04 Option Award(A) |
2021-12-17 5:57 pm |
N/A 2031-06-03 |
Zentalis Pharmaceuticals Inc. | ZNTL | Johnson David Michael Director |
30,000 | $0 | 118,855 (Direct) |
View |
| 2021-11-26 Gift(A) |
2021-12-07 8:35 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
125,000 | $0 | 1,332,309 (Indirect) |
View |
| 2021-11-26 Gift |
2021-12-02 7:16 pm |
N/A N/A |
Zentalis Pharmaceuticals Inc. | ZNTL | SUN ANTHONY Y President & CEO |
125,000 | $0 | 2,645,211 (Direct) |
View |